46 related articles for article (PubMed ID: 15773282)
1. Degradation of omeprazole induced by enteric polymer solutions and aqueous dispersions: HPLC investigations.
Riedel A; Leopold CS
Drug Dev Ind Pharm; 2005 Jan; 31(2):151-60. PubMed ID: 15773282
[TBL] [Abstract][Full Text] [Related]
2. Optimisation of the Manufacturing Process of Organic-Solvent-Free Omeprazole Enteric Pellets for the Paediatric Population: Full Factorial Design.
Rouaz-El-Hajoui K; García-Montoya E; López-Urbano A; Romero-Obon M; Chiclana-Rodríguez B; Fraschi-Nieto A; Nardi-Ricart A; Suñé-Pou M; Suñé-Negre JM; Pérez-Lozano P
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004567
[TBL] [Abstract][Full Text] [Related]
3. Tuning Molecular Orientation Responses of Microfluidic Liquid Crystal Dispersions to Colloid and Polymer Flows.
Bezrukov A; Galyametdinov Y
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686359
[TBL] [Abstract][Full Text] [Related]
4. A Polymer Model of the Whole Genome.
Schiessel H
Biophys J; 2020 Nov; 119(9):1699-1700. PubMed ID: 33010235
[No Abstract] [Full Text] [Related]
5. Kinetics of omeprazole degradation in solid state.
Popielarz-Brzezińska M
Acta Pol Pharm; 2011; 68(5):753-7. PubMed ID: 21928721
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole: a novel antisecretory agent for the treatment of acid-peptic disorders.
Lampkin TA; Ouellet D; Hak LJ; Dukes GE
DICP; 1990 Apr; 24(4):393-402. PubMed ID: 2183494
[TBL] [Abstract][Full Text] [Related]
7. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences.
Honig PK; Wortham DC; Zamani K; Conner DP; Mullin JC; Cantilena LR
JAMA; 1993 Mar 24-31; 269(12):1513-8. PubMed ID: 8445813
[TBL] [Abstract][Full Text] [Related]
8. Review article: immediate-release proton-pump inhibitor therapy--potential advantages.
Howden CW
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():25-30. PubMed ID: 16303034
[TBL] [Abstract][Full Text] [Related]
9. Identification of the acid-induced degradation products of omeprazole and 5-hydroxyomeprazole by high-resolution mass spectrometry.
Roberts J; McNaughtan ML; MacLachlan J; Hunter C; Pahl O
Rapid Commun Mass Spectrom; 2018 Jun; 32(12):929-941. PubMed ID: 29569771
[TBL] [Abstract][Full Text] [Related]
10. Analytical methodologies for the determination of omeprazole: an overview.
Espinosa Bosch M; Ruiz Sánchez AJ; Sánchez Rojas F; Bosch Ojeda C
J Pharm Biomed Anal; 2007 Aug; 44(4):831-44. PubMed ID: 17532167
[TBL] [Abstract][Full Text] [Related]
11. Emerging Applications of Hydroxypropyl Methylcellulose Acetate Succinate: Different Aspects in Drug Delivery and Its Commercial Potential.
Choudhari M; Damle S; Saha RN; Dubey SK; Singhvi G
AAPS PharmSciTech; 2023 Sep; 24(7):188. PubMed ID: 37715004
[TBL] [Abstract][Full Text] [Related]
12. Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer.
Nguyen HT; Van Duong T; Jaw-Tsai S; Bruning-Barry R; Pande P; Taneja R; Taylor LS
Mol Pharm; 2023 Jun; 20(6):3170-3186. PubMed ID: 37220082
[TBL] [Abstract][Full Text] [Related]
13. Molecular Interactions between APIs and Enteric Polymeric Excipients in Solid Dispersion: Insights from Molecular Simulations and Experiments.
Gupta KM; Chin X; Kanaujia P
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111649
[TBL] [Abstract][Full Text] [Related]
14. Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers.
Nguyen HT; Van Duong T; Taylor LS
Mol Pharm; 2023 Mar; 20(3):1681-1695. PubMed ID: 36730186
[TBL] [Abstract][Full Text] [Related]
15. Formulation of Dosage Forms with Proton Pump Inhibitors: State of the Art, Challenges and Future Perspectives.
Srebro J; Brniak W; Mendyk A
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297478
[TBL] [Abstract][Full Text] [Related]
16. Effect of Elevated pH on the Commercial Enteric-Coated Omeprazole Pellets Resistance: Patent Review and Multisource Generics Comparison.
Mohylyuk V; Yerkhova A; Katynska M; Sirko V; Patel K
AAPS PharmSciTech; 2021 Jun; 22(5):188. PubMed ID: 34159427
[TBL] [Abstract][Full Text] [Related]
17. A versatile, compartmentalised gut-on-a-chip system for pharmacological and toxicological analyses.
de Haan P; Santbergen MJC; van der Zande M; Bouwmeester H; Nielen MWF; Verpoorte E
Sci Rep; 2021 Mar; 11(1):4920. PubMed ID: 33649376
[TBL] [Abstract][Full Text] [Related]
18. Overview of Extensively Employed Polymeric Carriers in Solid Dispersion Technology.
Nair AR; Lakshman YD; Anand VSK; Sree KSN; Bhat K; Dengale SJ
AAPS PharmSciTech; 2020 Nov; 21(8):309. PubMed ID: 33161493
[TBL] [Abstract][Full Text] [Related]
19. Cellulose based polymers in development of amorphous solid dispersions.
Chavan RB; Rathi S; Jyothi VGSS; Shastri NR
Asian J Pharm Sci; 2019 May; 14(3):248-264. PubMed ID: 32104456
[TBL] [Abstract][Full Text] [Related]
20. Using zeta potential to study the ionisation behaviour of polymers employed in modified-release dosage forms and estimating their pK
Barbosa JAC; Abdelsadig MSE; Conway BR; Merchant HA
Int J Pharm X; 2019 Dec; 1():100024. PubMed ID: 31517289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
